Xu B, Zhang Q, Sun T, et al.Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trial, The Breast, Volume 80, 2025, 104413, ISSN 0960-9776, http://doi.org/10.1016/j.breast.2025.104413.
The Breast
